Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE: 002223)
China
· Delayed Price · Currency is CNY 35.07
-0.61 (-1.71%)
Jan 3, 2025, 3:04 PM CST
Jiangsu Yuyue Medical Equipment & Supply Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 7,284 | 7,919 | 7,034 | 6,831 | 6,666 | 4,582 | Upgrade
|
| Other Revenue | 52.81 | 52.81 | 67.77 | 63.18 | 59.94 | 54.27 | Upgrade
|
| Revenue | 7,337 | 7,972 | 7,102 | 6,894 | 6,726 | 4,636 | Upgrade
|
| Revenue Growth (YoY) | -15.17% | 12.25% | 3.01% | 2.51% | 45.08% | 10.82% | Upgrade
|
| Cost of Revenue | 3,685 | 3,906 | 3,709 | 3,586 | 3,189 | 2,684 | Upgrade
|
| Gross Profit | 3,652 | 4,066 | 3,393 | 3,308 | 3,537 | 1,952 | Upgrade
|
| Selling, General & Admin | 1,605 | 1,509 | 1,452 | 1,334 | 1,114 | 896.27 | Upgrade
|
| Research & Development | 512.17 | 504.37 | 496.4 | 425.67 | 401.52 | 235.07 | Upgrade
|
| Other Operating Expenses | 51.71 | 36.68 | 44.67 | 31.99 | 27.28 | 13.94 | Upgrade
|
| Operating Expenses | 2,170 | 2,041 | 2,006 | 1,818 | 1,528 | 1,158 | Upgrade
|
| Operating Income | 1,482 | 2,025 | 1,387 | 1,490 | 2,009 | 794.42 | Upgrade
|
| Interest Expense | -30.73 | -58.55 | -57.74 | -30.49 | -15.25 | -8.19 | Upgrade
|
| Interest & Investment Income | 298.78 | 357.97 | 185.19 | 156.79 | 153.1 | 35.64 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.66 | 3.66 | 99.33 | -0.04 | -138.06 | 5.83 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.84 | -2.41 | -1.4 | -1.79 | -0.59 | 0.7 | Upgrade
|
| EBT Excluding Unusual Items | 1,766 | 2,326 | 1,612 | 1,614 | 2,008 | 828.41 | Upgrade
|
| Impairment of Goodwill | -40.95 | -40.95 | -77.43 | - | -29.66 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -9.15 | -4.11 | 2.16 | 2.17 | -0.32 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 17.66 | 555.26 | 170.7 | 0.29 | -5.88 | 0.33 | Upgrade
|
| Asset Writedown | 18.7 | -13.66 | -1.99 | -0.86 | -0.12 | -1.99 | Upgrade
|
| Other Unusual Items | 282.91 | 26.76 | 136.63 | 85.75 | 46.72 | 37.59 | Upgrade
|
| Pretax Income | 2,035 | 2,849 | 1,842 | 1,702 | 2,019 | 864.34 | Upgrade
|
| Income Tax Expense | 301.61 | 472.36 | 269.73 | 217.82 | 262.04 | 102.77 | Upgrade
|
| Earnings From Continuing Operations | 1,733 | 2,376 | 1,573 | 1,484 | 1,757 | 761.57 | Upgrade
|
| Minority Interest in Earnings | 3.69 | 19.38 | 22.35 | -1.6 | 2.45 | -9.01 | Upgrade
|
| Net Income | 1,737 | 2,396 | 1,595 | 1,482 | 1,759 | 752.57 | Upgrade
|
| Net Income to Common | 1,737 | 2,396 | 1,595 | 1,482 | 1,759 | 752.57 | Upgrade
|
| Net Income Growth | -34.47% | 50.21% | 7.60% | -15.73% | 133.74% | 3.49% | Upgrade
|
| Shares Outstanding (Basic) | 996 | 994 | 991 | 995 | 1,005 | 1,003 | Upgrade
|
| Shares Outstanding (Diluted) | 996 | 994 | 991 | 995 | 1,005 | 1,003 | Upgrade
|
| Shares Change (YoY) | 1.23% | 0.35% | -0.42% | -1.02% | 0.17% | 0.73% | Upgrade
|
| EPS (Basic) | 1.74 | 2.41 | 1.61 | 1.49 | 1.75 | 0.75 | Upgrade
|
| EPS (Diluted) | 1.74 | 2.41 | 1.61 | 1.49 | 1.75 | 0.75 | Upgrade
|
| EPS Growth | -35.26% | 49.69% | 8.05% | -14.86% | 133.33% | 2.74% | Upgrade
|
| Free Cash Flow | 1,665 | 1,994 | 1,926 | 916.88 | 2,152 | 173.81 | Upgrade
|
| Free Cash Flow Per Share | 1.67 | 2.01 | 1.94 | 0.92 | 2.14 | 0.17 | Upgrade
|
| Dividend Per Share | 1.200 | 0.800 | 0.600 | 0.300 | 0.300 | 0.400 | Upgrade
|
| Dividend Growth | 100.00% | 33.33% | 100.00% | 0% | -25.00% | 166.67% | Upgrade
|
| Gross Margin | 49.77% | 51.00% | 47.77% | 47.99% | 52.59% | 42.11% | Upgrade
|
| Operating Margin | 20.20% | 25.40% | 19.53% | 21.61% | 29.87% | 17.14% | Upgrade
|
| Profit Margin | 23.67% | 30.05% | 22.46% | 21.50% | 26.15% | 16.23% | Upgrade
|
| Free Cash Flow Margin | 22.70% | 25.02% | 27.11% | 13.30% | 32.00% | 3.75% | Upgrade
|
| EBITDA | 1,691 | 2,230 | 1,586 | 1,677 | 2,170 | 890.7 | Upgrade
|
| EBITDA Margin | 23.05% | 27.97% | 22.33% | 24.33% | 32.26% | 19.21% | Upgrade
|
| D&A For EBITDA | 209.11 | 204.92 | 199.14 | 187.27 | 161.02 | 96.29 | Upgrade
|
| EBIT | 1,482 | 2,025 | 1,387 | 1,490 | 2,009 | 794.42 | Upgrade
|
| EBIT Margin | 20.20% | 25.40% | 19.53% | 21.61% | 29.87% | 17.14% | Upgrade
|
| Effective Tax Rate | 14.82% | 16.58% | 14.64% | 12.80% | 12.98% | 11.89% | Upgrade
|
| Revenue as Reported | 7,337 | 7,972 | 7,102 | 6,894 | 6,726 | 4,636 | Upgrade
|
| Advertising Expenses | - | 121.54 | 147.18 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.